NCT07045688 Efficacy of Vonoprazan Based Dual and Triple Therapy for Patient With Helicobacter Pylori Infection
| NCT ID | NCT07045688 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sohag University |
| Condition | H. Pylori Infection |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2025-05-13 |
| Primary Completion | 2025-11-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2025-05-13 with a primary completion date of 2025-11-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to assess Efficacy of vonoprazan based dual and triple therapy for naïve patient with Helicopacter Pylori infection in Sohag Government .
Eligibility Criteria
Inclusion Criteria: * Age: \>18 years old. * H. pylori infection: Confirmed by histopathology or non-invasive tests (e.g., stool antigen test). Exclusion Criteria: * Prior H. pylori treatment: Previous treatment for H. pylori infection. * Allergies: Known allergies to study medications or components. * Patients cannot finish treatment course. * Patient missed follow up. * Patients refusing or neglecting test of cure for H. pylori.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07045688 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, studying H. Pylori Infection. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07045688 currently recruiting?
Yes, NCT07045688 is actively recruiting participants. Contact the research team at andrewkameel511@gmail.com for enrollment information.
Where is the NCT07045688 trial being conducted?
This trial is being conducted at Sohag, Egypt.
Who is sponsoring the NCT07045688 clinical trial?
NCT07045688 is sponsored by Sohag University. The trial plans to enroll 150 participants.